3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Supraventricular Tachycardia
Supraventricular Tachycardia (SVT) is a cardiac arrhythmia characterized by an abnormally fast heartbeat originating above the heart's ventricles. This condition is often caused by abnormal electrical pathways in the heart, leading to rapid and irregular heartbeats. SVT episodes can be brief or prolonged, causing symptoms such as palpitations, dizziness, and shortness of breath. While generally not life-threatening, SVT can significantly impact an individual's quality of life. Treatment options range from lifestyle modifications and medications to more invasive procedures like catheter ablation, aiming to restore a normal heart rhythm. Proper diagnosis and management of SVT are crucial to alleviate symptoms and prevent potential complications associated with this common heart rhythm disorder.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United StatesSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation